Talphera, Inc.
General ticker "TLPH" information:
- Sector: Health Care
- Industry: Drug Manufacturers - Specialty & Generic
- Capitalization: $35.5M (TTM average)
Talphera, Inc. follows the US Stock Market performance with the rate: 28.3%.
Estimated limits based on current volatility of 5.4%: low 1.01$, high 1.12$
Factors to consider:
- Total employees count: 12 (-7.7%) as of 2025
- Top business risk factors: Capital constraints, Regulatory and compliance, Clinical trial failure, Labor/talent shortage/retention, Supply chain disruptions
- Price in estimated range
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [0.63$, 1.79$]
- 2026-12-31 to 2027-12-31 estimated range: [0.43$, 1.29$]
Financial Metrics affecting the TLPH estimates:
- Positive: with PPE of -2.6 at the end of fiscal year the price was neutral
- Negative: negative Operating cash flow
- Negative: negative Operating income
- Positive: Industry inventory ratio change (median), % of 0.12 <= 0.28
- Positive: 42.57 < Shareholder equity ratio, % of 57.32 <= 64.23
- Negative: negative Net income
- Positive: Interest expense per share per price, % of 0 <= 0.01
Short-term TLPH quotes
Long-term TLPH plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.65MM | $0.00MM | $0.03MM |
| Operating Expenses | $17.54MM | $15.25MM | $13.51MM |
| Operating Income | $-16.89MM | $-15.25MM | $-13.48MM |
| Non-Operating Income | $6.60MM | $2.25MM | $-0.88MM |
| Interest Expense | $0.13MM | $0.00MM | $0.00MM |
| R&D Expense | $5.55MM | $6.72MM | $6.03MM |
| Income(Loss) | $-10.29MM | $-13.00MM | $-14.36MM |
| Other Income(Loss) | $-8.11MM | $0.00MM | $0.07MM |
| Net Income(Loss)* | $-18.40MM | $-13.00MM | $-14.29MM |
| Stockholders Equity | $14.11MM | $8.00MM | $17.04MM |
| Assets | $20.39MM | $18.24MM | $29.72MM |
| Operating Cash Flow | $-17.49MM | $-12.68MM | $-11.36MM |
| Capital expenditure | $0.10MM | $0.00MM | $0.00MM |
| Investing Cash Flow | $-0.53MM | $3.78MM | $-14.35MM |
| Financing Cash Flow | $3.47MM | $12.04MM | $22.74MM |
| Earnings Per Share** | $-1.29 | $-0.50 | $-0.34 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.